Cyient Shares Drop 6% After Turning Ex-Record Date for Rs 720 Crore Buyback
Cyient's stock witnessed a significant 6% decline on Wednesday as the shares turned ex-record date for its upcoming share buyback program. The price correction follows the technical transition that makes new investors ineligible for the company's massive repurchase offer.
Understanding the Buyback and the Ex-Record Date Impact
The sudden dip in Cyient’s share price is largely attributed to the stock turning "ex-record date" on June 17. For the Rs 720 crore buyback, only shareholders who held the company's stock in their demat accounts as of the record date are eligible to participate.
Due to SEBI’s T+1 settlement rule, investors purchasing shares today will only see them credited to their accounts tomorrow, rendering them ineligible to tender shares for the buyback. Cyient has announced it will repurchase up to 64 lakh shares at a price of Rs 1,125 per share. This offer represents a substantial premium of approximately 24% over the previous closing price, a move typically designed to reward long-term shareholders and utilize surplus cash.
Historical Performance and Market Context
While the buyback offers a premium, Cyient’s broader stock performance has faced considerable headwinds. The company's shares have declined by nearly 23% in 2026 so far. Looking at longer timeframes, the volatility is even more pronounced: the stock has fallen 36% over the last year and 42% over the last three years, showing only marginal gains on a five-year horizon.
With a current market capitalization of less than Rs 9,540 crore, the company is navigating a period of stabilization. This buyback marks Cyient’s first such corporate action since 2019, as the management seeks to manage shareholder value amidst fluctuating market conditions.
Analyst Outlook: Growth Headwinds vs. Future Targets
Despite the buyback, market analysts remain cautious regarding the company's immediate trajectory. Emkay has maintained a 'Reduce' call on Cyient shares, although they have marginally increased their target price from Rs 850 to Rs 900. This new target implies a downside potential of less than 1% from the recent closing price of Rs 907.65.
La société de courtage a évoqué un ralentissement de la croissance pour l'exercice 2026 en raison de vents contraires macroéconomiques. Bien que les dépenses en recherche et développement en ingénierie (ER&D) restent saines avec une expansion comprise entre un chiffre simple moyen et élevé, des défis opérationnels spécifiques sont apparus. Notamment, le délai de rotation des stocks DLM a augmenté de 63 jours, sous l'effet d'un chiffre d'affaires faible, des exigences de programmes spécifiques aux clients et des perturbations de la chaîne d'approvisionnement mondiale. Toutefois, il y a une lueur d'espoir, car la direction vise une croissance plus forte et plus rentable pour l'exercice 2027.
Points clés
- Détails du rachat d'actions : Cyient procède à un rachat d'actions de 720 crores de roupies à 1 125 roupies par action, offrant une prime de 24 %, mais les nouveaux acheteurs ne sont pas éligibles en raison de la date ex-record.
- Performance de l'action : L'entreprise a connu des difficultés avec une baisse de 23 % en 2026 et une chute de 36 % au cours de l'année écoulée.
- Sentiment des analystes : Emkay maintient une recommandation « Réduire », notant que bien que les dépenses en ER&D soient saines, les vents contraires macroéconomiques et les défis liés aux stocks ont impacté la croissance de l'exercice 2026.